BioHarvest Sciences Inc.
BHSC
CNSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 8.50% | 12.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.50% | 12.78% | |||
| Cost of Revenue | -3.42% | 24.95% | |||
| Gross Profit | 19.73% | 3.30% | |||
| SG&A Expenses | 19.74% | 11.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.74% | 15.29% | |||
| Operating Income | -18.36% | -24.72% | |||
| Income Before Tax | -291.41% | 89.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -291.41% | 89.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -291.41% | 89.56% | |||
| EBIT | -18.36% | -24.72% | |||
| EBITDA | -23.40% | -16.12% | |||
| EPS Basic | -269.29% | 91.23% | |||
| Normalized Basic EPS | -268.44% | 91.21% | |||
| EPS Diluted | -269.29% | 91.23% | |||
| Normalized Diluted EPS | -268.44% | 91.21% | |||
| Average Basic Shares Outstanding | 6.07% | 18.93% | |||
| Average Diluted Shares Outstanding | 6.07% | 18.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
